Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia
Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
We hypothesize that the combination treatment with deferasirox and deferiprone will be well
tolerated and will result in significant improvement in cardiac and liver iron levels.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborators:
Ann & Robert H Lurie Children's Hospital of Chicago The Cooley's Anemia Foundation, The Cooley’s Anemia Foundation,